Home › Small Cell Lung Cancer › Illinois › Peoria
Small Cell Lung Cancer clinical trials in Peoria, IL
5 studies for Small Cell Lung Cancer are looking for participants at sites in and around Peoria (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RecruitingPhase 3
- OSF St. Francis Medical Center /ID# 279930, Peoria
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
RecruitingPhase 3
- Illinois Cancer Care, Peoria
- OSF St. Francis Medical Center, Peoria
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
RecruitingPhase 3
- Illinois Cancer Care, Peoria
Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer
RecruitingPhase 1
- OSF Saint Francis Medical Center, Peoria
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
RecruitingObservational study
- Illinois Cancer Care, Peoria
Small Cell Lung Cancer trials in other cities
- Houston, TX26 studies
- Arlington, VA23 studies
- Boston, MA21 studies
- New York City, NY21 studies
- Los Angeles, CA20 studies
- Nashville, TN20 studies
- Orlando, FL15 studies
- Dallas, TX13 studies
- St. Louis, MO13 studies
- Cleveland, OH13 studies
- Detroit, MI12 studies
- Washington, DC12 studies
Other studies in Peoria
- Non-Small Cell Lung Cancer21 studies
- Lung Cancer12 studies
- Colorectal Cancer12 studies
- Prostate Cancer9 studies
- Heart Failure8 studies
- Breast Cancer8 studies
- Ovarian Cancer7 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Metastatic Cancer7 studies
- Pancreatic Cancer7 studies
- Cancer (all types)7 studies
- Melanoma6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.